Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.

Nilselid AM, Davidsson P, Nägga K, Andreasen N, Fredman P, Blennow K.

Neurochem Int. 2006 Jun;48(8):718-28. Epub 2006 Feb 21.

PMID:
16490286
2.

Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease.

Tsuboi Y, Kakimoto K, Nakajima M, Akatsu H, Yamamoto T, Ogawa K, Ohnishi T, Daikuhara Y, Yamada T.

Acta Neurol Scand. 2003 Feb;107(2):81-6. Review.

PMID:
12580855
3.

Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.

Silverberg GD, Mayo M, Saul T, Carvalho J, McGuire D.

Expert Rev Neurother. 2004 Jan;4(1):97-107. Review.

PMID:
15853620
4.

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

Swerdlow RH.

Neurobiol Aging. 2007 Oct;28(10):1465-80. Epub 2006 Jul 31. Review.

PMID:
16876913
5.

Relationship between multifunctional protein "clusterin" and Alzheimer disease.

Choi-Miura NH, Oda T.

Neurobiol Aging. 1996 Sep-Oct;17(5):717-22. Review.

PMID:
8892344
6.

Intracellular amyloid-beta in Alzheimer's disease.

LaFerla FM, Green KN, Oddo S.

Nat Rev Neurosci. 2007 Jul;8(7):499-509. Review.

PMID:
17551515
7.

Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?

Funke SA, Birkmann E, Willbold D.

Curr Alzheimer Res. 2009 Jun;6(3):285-9. Review.

PMID:
19519310
8.

Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.

D'Ascenzo M, Relkin NR, Lee KH.

Curr Opin Mol Ther. 2005 Dec;7(6):557-64. Review.

PMID:
16372405
9.

[Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: a review of the literature and of current developments].

van Gool WA, Bolhuis PA.

Tijdschr Gerontol Geriatr. 1992 Dec;23(6):212-6. Review. Dutch.

PMID:
1362298
10.

Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.

Ventriglia M, Bucossi S, Panetta V, Squitti R.

J Alzheimers Dis. 2012;30(4):981-4. doi: 10.3233/JAD-2012-120244. Review.

PMID:
22475798
11.

Neuropeptides and Alzheimer's disease.

Gottfries CG, Frederiksen SO, Heilig M.

Eur Neuropsychopharmacol. 1995 Dec;5(4):491-500. Review.

PMID:
8998402
12.

The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Yu JT, Tan L.

Mol Neurobiol. 2012 Apr;45(2):314-26. doi: 10.1007/s12035-012-8237-1. Epub 2012 Jan 25. Review.

PMID:
22274961
13.

[Alzheimer disease, markers in the cerebrospinal fluid. Support of physiopathologic hypotheses].

Blain H, Jeandel C.

Presse Med. 1998 Apr 18;27(15):731-8. Review. French.

PMID:
9767915
14.

Sulfated glycoprotein-2: an emerging molecular marker for neurodegeneration.

May PC.

Ann N Y Acad Sci. 1993 May 28;679:235-44. Review. No abstract available.

PMID:
8512186
15.

[Analysis of beta-"trace" protein detects leakage of cerebrospinal fluid. Quickly, safely and cheaply].

Larsson A, Deuschl H, Flodin M, Ronquist G.

Lakartidningen. 2003 Mar 13;100(11):943-5. Review. Swedish.

PMID:
15148721
16.

New biochemical markers in Alzheimer disease.

Diaz-Arrastia R, Baskin F.

Arch Neurol. 2001 Mar;58(3):354-6. Review. No abstract available.

PMID:
11255437
17.

Analysis of cerebrospinal fluid and its clinical application.

Ranga S, Thool A, Khurana SK, Shahi SK, Talib VH.

Indian J Pathol Microbiol. 1998 Apr;41(2):173-92. Review. No abstract available.

PMID:
9670630
18.

Somatostatin in cerebrospinal fluid.

Cooper PE.

Bull Clin Neurosci. 1985;50:26-9. Review. No abstract available.

PMID:
2876739
19.

Mini symposium: the role of carbohydrates in reproduction. Introduction.

Ivell R.

Hum Reprod Update. 1999 Jul-Aug;5(4):277-9. Review. No abstract available.

PMID:
10465519

Supplemental Content

Support Center